Sydney Rosen

Research Associate Professor, International Health

Kennedy School of Government, Harvard University, MPA

  • Office: Crosstown Center, CT390
  • Phone: 617-414-1273
  • Email: sbrosen@bu.edu

Biography

Sydney Rosen, MPA, is Research Associate Professor at the Center for Global Health & Development at Boston University and the Co-Director of the Health Economics and Epidemiology Research Office (HE2RO) of the Wits Health Consortium at the University of the Witwatersrand in Johannesburg, South Africa. Her research addresses the economic consequences of the HIV/AIDS epidemic, including the impact of HIV/AIDS on households, private sector companies, and public sector agencies in sub-Saharan Africa; the benefits and costs of prevention and treatment interventions; and sectoral and societal responses to the epidemic. She is the principal investigator of USAID-, CDC-, NIH-, and foundation-supported evaluations of the outcomes, costs, benefits, and cost-effectiveness of care and treatment for HIV/AIDS in South Africa, Zambia, and Kenya. Her current research focuses on the costs and cost-effectiveness of different strategies for large-scale antiretroviral treatment provision. She is also the author of policy and review papers on the business response to AIDS, the rationing of antiretroviral therapy, and the retention of patients in AIDS treatment programs. Her research has been published in The Lancet, PloS Medicine, AIDS, JAIDS, the Bulletin of the World Health Organization, Tropical Medicine and International Health, and other international journals. In 2003 she won the Harvard Business Review’s McKinsey Award, given to the most influential Harvard Business Review article of the year, for her article titled “AIDS is Your Business.” Professor Rosen’s technical training is in policy analysis and applied economics. She holds a BA magna cum laude from Harvard University and an MPA from the Kennedy School of Government at Harvard.

Projects

Publications

Retention on Antiretroviral Therapy in South Africa: Evidence from a Systematic Review 2008-2013

Sydney Rosen, Matthew Fox

Health Economics and Epidemiology Research Office (HE2RO); 2014 Jun.

Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study

Callie A Scott, Hari S Iyer, Kelly McCoy, Crispin Moyo, Lawrence Long, Bruce A Larson, and Sydney Rosen

BMC Public Health. 2014 Mar; 14(296).

Effect of antiretroviral therapy on patients’ economic well-being: five-year follow up in South Africa

Sydney Rosen; Bruce Larson; Julia Rohr; Ian Sanne; Constance Mongwenyana; Alana T. Brennan; Omar Galárraga

AIDS. 2013 Sep;.

Uptake, Outcomes, and Costs of Antenatal, Well-Baby, and Prevention of Mother-to-Child Transmission of HIV Services under Routine Care Conditions in Zambia

Callie A. Scott, Hari S. Iyer, Deophine Lembela Bwalya, Maximillian Bweupe, Sydney B. Rosen, Nancy Scott, Bruce A. Larson

PLOS ONE. 2013 Aug; 8(8).

Same-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not Enough

Bruce A. Larson, Kathryn Schnippel, Alana Brennan, Lawrence Long, Thembi Xulu, Thapelo Maotoe, Sydney Rosen, Ian Sanne, and Matthew P. Fox

AIDS Research and Treatment. 2013 Jun; 2013:1-7.

Retention in Care and Outpatient Costs for Children Receiving Antiretroviral Therapy in Zambia: A Retrospective Cohort Analysis

Callie A. Scott, Hari Iyer, Deophine Lembela Bwalya, Kelly McCoy, Gesine Meyer-Rath, Crispin Moyo, Carolyn Bolton-Moore, Bruce Larson, and Sydney Rosen

PLoS ONE. 2013 Jun; 8(6).

Diagnosing Xpert MTB/RIF-negative TB: Impact and cost of alternative algorithms for South Africa

K Schnippel, G Meyer-Rath, L Long, W S Stevens, I Sanne, S Rosen

The South African Medical Journal. 2013 Feb; 103(2).

Cost and Outcomes of Paediatric Antiretroviral Treatment in South Africa

Gesine Meyer-Rath, Alana Brennan, Lawrence Long, Buyiswa Ndibongo, Karl Technau, Harry Moultrie, Lee Fairlie, Ashraf Coovadia and Sydney Rosen

AIDS 2012. 2013 Jan; 14(27):243-250.

Antiretroviral Therapy, Labor Productivity, and Gender: A Longitudinal Cohort Study of Tea Pluckers in Kenya

Bruce.A. Larson, Matthew P. Fox, Margaret Bii, Sydney Rosen, Julia Rohr, Douglas Shaffer, Fredrick Sawe, Monique Wasunna and Jonathon L. Simon

AIDS 2012. 2013 Jan;.

Rates and Cost of Hospitalization Before and After Initiation of Antiretroviral Therapy in Urban and Rural Settings in South Africa

Gesine Meyer-Rath, Alana T. Brennan, Matthew P. Fox, Tebogo Modisenyane, Nkeko Tshabangu, Lerato Mohapi, Sydney Rosen, and Neil Martinson

JAIDS. 2013 Jan; 62(3):322-328.

ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics

Bruce A Larson, Margaret Bii, Sarah Henly-Thomas, Kelly McCoy, Fredrick Sawe, Douglas Shaffer, Sydney Rosen

Journal of the International AIDS Society. 2013 Jan; 16(18026).

HE2RO Policy Brief 6: THE Benefits of Antiretroviral Therapy for Patients’ Economic Well-Being

Rosen S, Larson B, Rohr J, Sanne I, Mongwenyana C, Brennan AT, Galarraga O

2013 Jan.

Costs of Inpatient Treatment for Multi-Drug Resistant Tuberculosis in South Africa

Kathryn Schnippel, Sydney Rosen, Kate Shearer, Neil Martinson, Lawrence Long, Ian Sanne and Ebrahim Variava

Tropical Medicine and International Health. 2012 Dec;.

Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa

Matthew P. Fox, Bruce Larson, and Sydney Rosen

Tropical Medicine and International Health. 2012 Aug; 00(00):1-10.

HIV treatment produces economic returns through increased work and education, and warrants continued US support

Harsha Thirumurthy, Omar Galárraga, Bruce Larson, & Sydney Rosen

Health Affairs. 2012 Jul; 31(7):1470-1477.

Scaling up Xpert MTB⁄RIF technology: the costs of laboratory vs. clinic-based roll-out in South Africa

Kathryn Schnippel, Gesine Meyer-Rath, Lawrence Long, William MacLeod, Ian Sanne, Wendy S. Stevens and Sydney Rosen

Tropical Medicine and International Health. 2012 Jun; 00(00):1-10.

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen

PLoS ONE. 2012 May; 7(5):1-11.

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere PimaTM Analyzer in South Africa

Bruce Larson, Kathryn Schnippel, Buyiswa Ndibongo, Lawrence Long, Matthew P. Fox, & Sydney Rosen

PLoS ONE. 2012 Apr; 7(4):1-8.

Rapid, Point-of-Care CD4 Testing At Mobile and Fixed HIV Testing Sites: Does It Increase Linkage to HIV Care?

Larson B., Schnippel K., Ndibongo B., Brennan A., Xulu T., Long L., Fox M., Sanne I., Rosen S.

Health Economics and Epidemiology Research Office (HERO). 2011 Nov; 3:1-2.

The Net Cost of Incorporating Resistance Testing into HIV/AIDS Treatment in South Africa: A Markov Model with Primary Data

Sydney R., Long L., Sanne I., Stevens W., Fox M.P.

Journal of International AIDS Society. 2011 Jul; 14(24):1-6.

Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort

Long L., Brennan A., Fox M.P., Ndibongo B., Jaffray I., Sanne I., Rosen S.

PLOS Medicine. 2011 Jul; 8(7):1-10.

The Incremental Cost Of Introducing Xpert® MTB/RIF into the South African National Tuberculosis Programme

Meyer-Rath G., Bistline K., Long L., MacLeod W., Sanne I., Stevens W., Rosen S.

Johannesburg, South Africa; Boston, MA: Health Economics and Epidemiology Research Office, Wits Health Consortium, University of the Witwatersrand (HE2RO); 2011 Jul.

Lost Opportunities to Complete CD4+ Lymphocyte Testing Among Patients Who Tested Positive for HIV in South Africa

Larson B.A., Brennan A., McNamara L., Long L., Rosen S., Sanne I., Fox M.P.

Bull World Health Organ. 2010 Sep; 88(9):675-80.

Total Cost and Potential Cost Savings of the National Antiretroviral Treatment (ART) Programme in South Africa 2010 to 2017. Abstract 16112

Meyer-Rath G., Brennan A., Long L., Rosen S., Pillay Y., Johnson L., Mbengashe T., Dlamini N., Fox M.P.

18th International AIDS Conference; 2010 Jul 18; Vienna.

Early Loss to Follow Up After Enrolment in Pre-ART Care at a Large Public Clinic in Johannesburg, South Africa

Larson B. A., Brennan A., McNamara L., Long L., Rosen S., Sanne I., Fox M. P.

Trop Med Int Health. 2010 Jul; 15 Suppl 1:43-7.

Why are Antiretroviral Treatment Patients Lost to Follow-Up? A Qualitative Study from South Africa

Miller C. M., Ketlhapile M., Rybasack-Smith H., Rosen S.

Trop Med Int Health. 2010 Jul; 15 Suppl 1:48-54.

Improvements in Physical Wellbeing over the First Two Years on Antiretroviral Therapy in Western Kenya

Fox M. P., McCoy K., Larson B. A., Rosen S., Bii M., Sigei C., Shaffer D., Sawe F., Wasunna M., Simon J. L.

AIDS Care. 2010 Apr; 22(2):137-45.

Survival in Care and CD4 Cell Count Gain on First-line ART Depend on Prior CD4 Cell Count and Time on Treatment: Evidence From a Large South African Cohort. Abstract Z-184

Meyer-Rath G., Brennan A., Long L., Rosen S.B., Fox M.P.

17th Conference on Retroviruses and Opportunistic Infections (CROI); 2010 Feb 1; San Francisco.

The High Cost of Second-Line Antiretroviral Therapy for HIV/AIDS in South Africa

Long L., Fox M., Sanne I., Rosen S.

AIDS. 2010 Jan; 24(6):915-9.

Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment

Rosen S., Larson B., Brennan A., Long L., Fox M., Mongwenyana C., Ketlhapile M., Sanne I.

PLoS ONE. 2010 Jan; 5(9):e12731.

Do the Socioeconomic Impacts of Antiretroviral Therapy Vary by Gender? A Longitudinal Study of Kenyan Agricultural Worker Employment Outcomes

Larson B. A., Fox M. P., Rosen S., Bii M., Sigei C., Shaffer D., Sawe F., McCoy K., Wasunna M., Simon J. L.

BMC Public Health. 2009 Jul; 9:240.

The Private Sector and HIV/AIDS in Africa: Recent Developments and Implications for Policy

Feeley F., Connelly P., Rosen S.

The changing HIV/AIDS landscape : selected papers for the World Bank's agenda for action in Africa, 2007-2011. Lule Elizabeth, Seifman Richard, David Antonio C., World Bank.. Washington DC: World Bank; 2009.

Cost and Cost-Effectiveness of Antiretroviral Treatment Delivery

Sydney Rosen, Lawrence Long, and Ian Sanneb

From the Ground Up: Developing Pathways and Partnerships. Richard G. Marlink and Sara J. Tietelman. published online: Elizabeth Glaser Pediatric AIDS Foundation; 2009.

Characteristics of Patients Accessing Care and Treatment for HIV/AIDS at Public and Nongovernmental Sites in South Africa

Rosen S., Ketlhapile M., Sanne I., DeSilva M. B.

J Int Assoc Physicians AIDS Care (Chic Ill). 2008 Jul; 7(4):200-7.

The Outcomes and Outpatient Costs of Different Models of Antiretroviral Treatment Delivery in South Africa

Rosen S., Long L., Sanne I.

Trop Med Int Health. 2008 Jul; 13(8):1005-15.

Cost and Cost-Effectiveness of Switching from Stavudine to Tenofovir in First-Line Antiretroviral Regimens in South Africa

Rosen S., Long L., Fox M., Sanne I.

J Acquir Immune Defic Syndr. 2008 Jun; 48(3):334-44.

Private Sector Provision and Financing of AIDS Treatment in Africa: Current Developments

Feeley F., Connelly P., Rosen S.

Curr HIV/AIDS Rep. 2008 Mar; 4(4):192-200.

Early Effects of Antiretroviral Therapy on Work Performance: Preliminary Results from a Cohort Study of Kenyan Agricultural Workers

Larson B. A., Fox M. P., Rosen S., Bii M., Sigei C., Shaffer D., Sawe F., Wasunna M., Simon J. L.

AIDS. 2008 Jan; 22(3):421-5.

Evaluating Outcomes and Costs for Different Models of Care

Rosen S, Long L.

From the Ground Up: A Guide to Comprehensive HIV/AIDS Care in Resource-Limited Settings. Marlink R, et al.. Santa Monica, CA: Elizabeth Glaser Pediatric AIDS Foundation; 2008.

Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review

Rosen S., Fox M. P., Gill C. J.

PLoS Med. 2007 Oct; 4(10):e298.

Cost to Patients of Obtaining Treatment for HIV/AIDS in South Africa

Rosen S., Ketlhapile M., Sanne I., DeSilva M. B.

S Afr Med J. 2007 Sep; 97(7):524-9.

The Private Sector and HIV/AIDS in Africa: Taking Stock of 6 years of Applied Research

Rosen S., Feeley F., Connelly P., Simon J.

AIDS. 2007 Aug; 21 Suppl 3:S41-51.

The Impact of AIDS on Government Service Delivery: the Case of the Zambia Wildlife Authority

Rosen S., Hamazakaza P., Feeley F., Fox M.

AIDS. 2007 Aug; 21 Suppl 3:S53-9.

Prevalence of HIV Infection and Median CD4 Counts among Health Care Workers in South Africa

Connelly D., Veriava Y., Roberts S., Tsotetsi J., Jordan A., DeSilva E., Rosen S., DeSilva M. B.

S Afr Med J. 2007 Apr; 97(2):115-20.

Illness and Labour Productivity: A Case Study from Kenya

Rosen S., Fox M. P., Simon J.

Health, Economic Development and Household Poverty: From Understanding to Action. Bennet S., Gilson L., Mills A.. London, England: Taylor and Francis, Routledge; 2007.

Treatment of HIV/AIDS at South Africa’s Largest Employers: Myth and Reality

Connelly P., Rosen S.

S Afr Med J. 2006 Mar; 96(2):128-33.

HIV/AIDS and the Private Sector in Africa: Impact and Responses. Report prepared for the Commission on HIV/AIDS and Governance in Africa

Rosen S., Bii M., Fox M., Hamazakaza P., Larson B., Long L., and Simon J.

Boston, MA: Center for International Health and Development; 2006 Feb.

The Impact of HIV/AIDS on the Judicial System In the Republic of Zambia

Feeley R., Banda M., Rosen S., Fox M.

Boston, MA: Center for International Health and Development, Boston University; 2006.

Rationing Antiretroviral Therapy for HIV/AIDS in Africa: Choices and Consequences

Rosen S., Sanne I., Collier A., Simon J. L.

PLoS Med. 2005 Sep; 2(11):e303.

Provision of Antiretroviral Therapy by the Private Sector

Connelly P., Rosen S.

Lancet. 2005 Jun; 365(9475):1925-6.

Hard Choices: Rationing Antiretroviral Therapy for HIV/AIDS in Africa

Rosen S., Sanne I., Collier A., Simon J. L.

Lancet. 2005 Jan; 365(9456):354-6.

Cost Impact of HIV/AIDS Infections in the Professional Labor Force in the Zambian Health Care System

Feeley F., Rosen S., Fox M., Macwan’gi M., Mazimba A.

XVth International AIDS Conference; 2004 Jul 1; Bangkok, Thailand.

The Cost of HIV/AIDS to Businesses in Southern Africa

Rosen S., Vincent J. R., MacLeod W., Fox M., Thea D. M., Simon J. L.

AIDS. 2004 Apr; 18(2):317-24.

Prevalence of HIV in Workforces in Southern Africa, 2000-2001

Evian C., Fox M., MacLeod W., Slotow S. J., Rosen S.

S Afr Med J. 2004 Mar; 94(2):125-30.

The Impact of HIV/AIDS on Labour Productivity in Kenya

Fox M. P., Rosen S., MacLeod W. B., Wasunna M., Bii M., Foglia G., Simon J. L.

Trop Med Int Health. 2004 Mar; 9(3):318-24.

The Costs of HIV/AIDS among Professional Staff in the Zambian Public Health Sector

Feeley F., Rosen S., Fox M., Macwan'gi M., Mazimba A.

Boston, MA: Center for International Health and Development; 2004.

Why do firms take action on HIV/AIDS? Evidence from Nigeria

Rosen S., Vincent J. R., MacLeod W., Thea D. M., Simon J.

Journal of Business in Developing Countries. 2004 Jan; 8(1):1-38.

Shifting the Burden: the Private Sector’s Response to the AIDS Epidemic in Africa

Rosen S., Simon J. L.

Bull World Health Organ. 2003 May; 81(2):131-7.

AIDS is Your Business

Rosen S., Simon J., Vincent J. R., MacLeod W., Fox M., Thea D. M.

Harv Bus Rev. 2003 Feb; 81(2):80-7, 125.

How Will the Reduction of Tariffs and Taxes on Insecticide- Treated Bednets Affect Household Purchases?

Simon J. L., Larson B. A., Zusman A., Rosen S.

Bull World Health Organ. 2002 Dec; 80(11):892-9.

Understanding Household Demand for Indoor Air Pollution Control in Developing Countries

Larson B. A., Rosen S.

Soc Sci Med. 2002 Aug; 55(4):571-84.

The Family Health Cycle – Creating a Context for Maternal and Child Health

Simon J., Rosen S.

Development Discussion Paper. Boston, MA: Harvard Institute for International Development; 2000.

The Economics of Air Pollution Health Risks in Russia: A Case Study of Volgograd

Larson B. A., Avaliani S., Golub A., Rosen S., Shaposhnikov D., Strukova E., Vincent J. R., Wolff S. K.

World Development. 1999 Oct; 27(10):1803-1819.

Exchanging Debt for Health in Africa: Lessons from Ten Years of Debt-for-Development Swaps

Rosen S., Simon J., Thea D., Zeitz P.

Development Discussion Paper. Boston, MA: Harvard Institute for International Development; 1999.